Published in
Elsevier, Diabetes Research and Clinical Practice, (173), p. 108681, 2021
DOI: 10.1016/j.diabres.2021.108681
Links
Tools
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: a 24 months follow-up study
Journal article published in 2021 by
Luca D'Onofrio 
,
Carmen Mignogna,
Angela Carlone,
Ermanno Bellizzi,
Michela Di Guida,
Chiara Moretti,
Simona Zampetti,
Gaetano Leto,
Ernesto Maddaloni,
Raffaella Buzzetti
,
Carmen Mignogna,
Angela Carlone,
Ermanno Bellizzi,
Michela Di Guida,
Chiara Moretti,
Simona Zampetti,
Gaetano Leto,
Ernesto Maddaloni,
Raffaella Buzzetti
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 